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Summary
AXH is a protein module identified in two unrelated
families that comprise the transcriptional repressor
HBP1 and ataxin-1 (ATX1), the protein responsible for
spinocerebellar ataxia type-1 (SCA1). SCA1 is a neu-
rodegenerative disorder associated with protein mis-
folding and formation of toxic intranuclear aggre-
gates. We have solved the structure in solution of
monomeric AXH from HBP1. The domain adopts a
nonclassical permutation of an OB fold and binds nu-
cleic acids, a function previously unidentified for this
region of HBP1. Comparison of HBP1 AXH with the
crystal structure of dimeric ATX1 AXH indicates that,
despite the significant sequence homology, the two
proteins have different topologies, suggesting that
AXH has chameleon properties. We further demon-
strate that HBP1 AXH remains monomeric, whereas
the ATX1 dimer spontaneously aggregates and forms
fibers. Our results describe an entirely novel, to our
knowledge, example of a chameleon fold and suggest
a link between these properties and the SCA1 patho-
genesis.
Introduction
The elegant plasticity by which proteins can adapt their
fold to specific environments is a topic that has recently
received increasing attention. Chameleon proteins, that
is molecules that can have different secondary and/or
tertiary structures according to the environment, have
been described in nature and have been designed
ab initio (Minor and Kim, 1996). Their interest is not only
academic since structural plasticity has been directly
linked to an increasing number of human diseases
whose cause has been associated with the ability of
specific proteins to misfold and form toxic aggregates
(Dobson, 1999, 2001). One such chameleon seems to
be the AXH module identified in proteins belonging to
two apparently unrelated protein families of great medi-
cal importance (Mushegian et al., 1997): the HMG box
transcription factor HBP1 and the polyglutamine (polyQ)-
containing ATX1 protein (Lesage et al., 1994; Banfi et
al., 1994).
First identified as a target for family members of the
retinoblastoma tumor suppressor (Lavender et al.,
1997; Tevosian et al., 1997), HBP1 acts both as a re-
pressor and as an activator of transcription by regulat-*Correspondence: apastor@nimr.mrc.ac.uking several genes, including those encoding cyclin D1,
MyoD, and N-myc (for an extensive review, see Yee et
al., 2004). It has also been suggested that HBP1 regu-
lates signaling pathways in cancer and acts as a tumor
suppressor by blocking the oncogenic gene expression
program. Recently, HBP1 was described to bind the his-
tone deacetylase-associated Sin3 corepressor (Swanson
et al., 2004). ATX1 is instead mainly known because,
when mutated, it causes the spinocerebellar ataxia
type-1 (SCA1), an autosomal-dominant neurodegenera-
tive disorder characterized by ataxia and progressive
motor deterioration (reviewed in Orr and Zoghbi, 2001).
Like at least seven other disorders, SCA1 is a misfold-
ing disease, in which expansion of a polymorphic poly-
glutamine (polyQ) tract present near the ATX1 N termi-
nus promotes the formation of intranuclear aggregates
and consequent cell death (Klement et al., 1998). The
exact role of nonpathological ATX1 is still unclear, al-
though recent evidence suggests that it is also a tran-
scription factor (Tsai et al., 2004). It has been described
to bind to RNA (Yue et al., 2001; Irwin et al., 2005) and to
be implicated in interactions with several other proteins
(Koshy et al., 1996; Matilla et al., 1997; Davidson et al.,
2000; Hong et al., 2002; Okazawa et al., 2002; Chen et
al., 2003).
The AXH motif seems to play an important role in the
functions of both protein families: in a previous paper,
we showed that AXH forms an independently folded
unit and that most of the known interactions of both
ATX1 and HBP1 with other protein partners map into
the AXH domain (de Chiara et al., 2003). The AXH of
ATX1 is also able to bind to RNA homopolymers with
the same sequence preference observed for the full-
length protein (de Chiara et al., 2003; Yue et al., 2001).
While clearly correlated (sharing a sequence identity
of ca. 30% and a homology of ca. 50% depending on
the species), AXH has slightly different domain bound-
aries and distinct properties in the two protein subfami-
lies (de Chiara et al., 2003). The AXH structure of ATX1
was recently solved crystallographically (Chen et al.,
2004). It consists of a noncanonical oligonucleotide and
oligosaccharide binding (OB) fold (Murzin, 1993), which
forms a dimer of asymmetric dimers. The dimer inter-
face is formed by “two mutually adapting yet different
20-residue chameleon motifs” (Chen et al., 2004). It is
probably the first example in which the existence of
alternative structures in a chameleon sequence is not
induced by mutations, ligand binding, or by a different
protein context. These findings raise the intriguing
question of whether the possibility of adopting different
topologies could be an intrinsic feature of the AXH mo-
tif that could also play a role in the SCA1 pathology.
To gain further insights into this hypothesis, we
solved the structure of the corresponding region of
HBP1, which, as opposed to the AXH of ATX1, is a mono-
mer (de Chiara et al., 2003). The structure was solved
in solution by nuclear magnetic resonance (NMR). Our
results show that, while sharing a similar overall OB
fold, the AXH of HBP1 has a topology distinct from that
of any of the ATX1 AXH monomers. The main differ-
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744ences are concentrated in the topology of regions that a
also show the maximal structural difference among the t
ATX1 subunits. We demonstrate that the ATX1 AXH do- 1
main, but not AXH from HBP1, has a strong tendency r
to aggregate and to form fibers. These results suggest p
that the AXH module is a domain with novel, to our w
knowledge, chameleon properties that, in given protein s
contexts, can be trapped in nonnative conformations
and participate to misfolding. s
s
oResults
p
(The Monomeric AXH Domain of HBP1
1Has an OB Fold
tWe have already reported elsewhere that a construct
aspanning residues 208–345 of HBP1 (hereafter indi-
(cated as HBP1_AXH) comprises the minimal length to
oobtain a folded AXH domain (de Chiara et al., 2003).
αThis region was shown to be monomeric in solution up
dto micromolar concentrations by analytical ultracentrif-
ugation studies. To confirm that the monomeric species (Figure 1. Tertiary Structure of ATX1_HBP1 and Indicators of Its Backbone Dynamics
(A) Comparison between the NMR relaxation parameters with the rmsd of the backbone atoms along the sequence. The secondary structure
elements are indicated on the top (cylinders and arrows indicate helices and sheets, respectively). The T1 and T2 data were collected at 600
MHz and 30°C on a 0.4 mM sample in 20 mM Tris-HCl (pH 7.0) with 10 mM NaCl, 2 mM β-mercaptoethanol, and 0.02% NaN3. Heteronuclear
NOE data were recorded on the same sample at 800 MHz and 30°C.
(B) NMR bundle of the 20 lowest energy structures.
(C) Representation of the average structure as calculated according to Thomas and Pastore (2005).lso remains prevalent at NMR (millimolar) concentra-
ions, we carried out 1H,15N relaxation studies (Figure
A). The correlation time, as estimated from T1 and T2
elaxation data by using the model-free approach of Li-
ari and Szabo, 1982, is 7.28 ± 0.12 ns at 30°C, a value
ell within the range expected for a single monomeric
pecies in solution.
Full NMR spectral assignment of HBP1_AXH, as de-
cribed elsewhere (de Chiara et al., 2004), allowed full
tructure determination. The final representative family
f 20 structures (Figure 1B) shows an excellent super-
osition with an overall root-mean-square deviation
rmsd) with the average structure of 0.50 ± 0.09 Å and
.04 ± 0.18 Å for backbone and heavy atoms, respec-
ively, in the structured regions. The structure quality,
s assessed by the standard indicators, is excellent
Table 1). The structure consists of two β sheets, made
f six and three strands, respectively, and of two short
helices (Figure 1C). The overall topology, as defined
irectly by numerous unambiguous long-range NOEs
for a full discussion on structure validation, see the
Solution Structure of the HBP1 AXH Module
745Table 1. Structural Statistics for the HBP1 AXH Domain
Final NMR Restraints
Total distance restraints 3615
Unambiguous/ambiguous 3048/567
Intraresidue 1256
Sequential 322
Medium (residue i to i + j, j = 2 − 4) 740
Long-range (residue i to i + j, j > 4) 1297
Dihedral angle restraintsa
f 156
ψ 74
χ1 34
1DNH RDC 58
Hydrogen bonds 31
Deviation from Idealized Geometry Without RDC With RDC
Bond lengths (Å) 0.004 ± 0.000 0.004 ± 0.000
Bond angles (°) 0.599 ± 0.010 0.625 ± 0.015
Improper dihedrals (°) 1.517 ± 0.051 1.640 ± 0.062
Restraint Violations
Distance restraint violation > 0.5 Å 0 0
Dihedral restraint violation > 5° 0 0
Coordinate Precision (Å) with Respect to the Mean Structure
Backbone of structured regionsb 0.40 ± 0.06 0.50 ± 0.09
Heavy atoms of structured regionsb 0.77 ± 0.08 1.04 ± 0.18
Backbone of secondary structure elementsc 0.27 ± 0.05 0.36 ± 0.08
Heavy atoms of secondary structure 0.65 ± 0.06 0.88 ± 0.15
elementsc
Whatif Quality Check
First generation packing quality −1.34 −1.05
Second generation packing quality −4.15 −3.54
Ramachandran plot appearance −2.94 −2.62
χ1-χ2 rotamer normality −1.17 −1.40
Backbone conformation −1.13 −1.25
Procheck Ramachandran Statistics
Most favored region 81.6% 80.5%
Additionally allowed regions 16.8% 17.4%
Generously allowed regions 1.5% 1.6%
Disallowed regions 0.1% 0.5%
Statistics were calculated for the 20 lowest energy structures after water refinement.
a Derived from 3J(HN, Hα) coupling constants and TALOS (Cornilescu et al., 1999).
b Residues 208–241 and 256–345.
c Residues 220–223, 232–241, 262–271, 275–283, 292–297, 301–304, 308–311, 314–321, 326–327, and 333–334.Supplemental Data available with this article online), is
β1β2α1β3β4β5β6β7α2β8β9. The first six strands form a
central all-antiparallel β sheet (β2β1β5β4β3β9). An addi-
tional triple-stranded β sheet is made of two antiparallel
strands (β6 and β7), and a third strand (β8) that runs
parallel to β7. α1 packs against β1 and β2 and is followed
by a long unstructured region of 13 amino acids (resi-
dues 242–255), whereas α2 packs against β7 and β8.
The six-stranded β sheet defines an open β barrel
structure typical of an OB fold (Theobald et al., 2003),
in which each end of the barrel is capped by an α helix.
The triple-stranded sheet, together with the N terminus,
defines the internal cavity of the barrel. The N and C
termini are spatially close, and the structure is stabi-
lized by hydrophobic residues located in the core of
the barrel. Among these residues are most of the 22
aromatics that are distributed along the cavity of the
barrel in a herringbone arrangement. Overall, the struc-
ture is compact, lacks cavities or grooves, and is rela-
tively rigid. The only exception is the long unstructuredloop between α1 and β3 (residues 242–255), which ex-
hibits the highest local rmsd in the bundle (Figure 1A).
It forms a flexible finger that protrudes into solution.
Its intrinsic high flexibility is directly supported by the
relaxation parameters, which, in this region, differ sig-
nificantly from the average values (Figure 1A).
HBP1_AXH Has a Topology Different
from that of ATX1 AXH
The solution structure of HBP1_AXH was then com-
pared with the crystallographic structure of the AXH
from ATX1 (Chen et al., 2004). The construct used com-
prises residues 563–694 of the ATX1 sequence. The
four monomers of ATX1 AXH (named A–D), which are
part of a dimer of dimers, have distinct structures and
overlap with each other with an average rmsd of 0.90 ±
0.06 Å only when superposing the backbone atoms of
residues 610–685 (Figure 2). Outside this region, there
are appreciable differences that are mostly localized at
the N and C termini. In the B monomer, α is also par-1
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746tially unraveled and forms a long loop that packs a
magainst the well-folded α1 helix of the nearby subunit C
(Figures 2A and 2B and see the Supplemental Data). a
2Notably, the regions with larger variability are directly
involved in the two dimer interfaces (the one between c
Aeach monomer and the one between the two dimers).
A detailed comparison of the AXH structures from t
0HBP1 and ATX1 reveals an even larger variability (Fig-
ures 2B and 2C). Overall, the ATX1 AXH monomer has β
aa sickle-like shape with the concave and convex sides
engaged in the interfaces between each dimer and be- H
βtween the two dimers, respectively, whereas the shape
of HBP1_AXH is that of a more globular, although elon- d
sgated, domain. The secondary structure elements are
the same in the two proteins, but they are arranged in aFigure 2. Comparison between the AXH Do-
mains of ATX1 and HBP1
(A) Structure of the dimer of dimers of ATX1
as observed in the crystal structure (PDB
identifier 1oa8). The subunits (A–D from left
to right) are alternatively indicated with dark
and light tones of green. Red circles indicate
the intermolecular interfaces between each
monomer in the dimer and between the two
asymmetric dimers. They include the N ter-
minus and helix α1, respectively.
(B) Structures of subunits A and B of the
AXH from ATX1.
(C) Structure of HBP1_AXH (left) and super-
position of the A subunit of ATX1 AXH and
HBP1_AXH (right). Only the structurally sim-
ilar regions are displayed. The positions of
the N and C termini and of the secondary
structure elements are indicated.significantly different topology. As among the ATX1
onomers, the differences are not uniformly distributed
long the sequence. The regions comprising residues
61–272, 277–284, and 291–335 in HBP1_AXH (which
orrespond to 613–624, 627–634, and 640–684 in ATX1
XH) superpose well with each of the ATX1 AXH subunits;
he average rmsd for the backbone atoms is 1.84 ±
.03 Å (Figure 2C). The N-terminal secondary elements
1, β2, and α1 have, on the contrary, a different spatial
rrangement compared to the rest of the molecule: in
BP1_AXH, β1 and β2 participate in the six-stranded
sheet that defines the central β barrel of the HBP1
omain, with helix α1 capping the barrel from the β2
ide. In the ATX1 AXH structure, α1 packs instead
gainst the opposite edge of the barrel (β side), and is9
Solution Structure of the HBP1 AXH Module
747Figure 3. Comparison between OB Topologies
(A–D) The structures of (A) HBP1_AXH and (B) ATX1_AXH (1oa8) are compared with those of the DNA binding domain A of (C) RPA (1fgu) and
the RNA binding domain of the (D) rho transcription terminator (1a8v), selected as representative examples of the OB fold (Theobald et al.,
2003). The secondary structure topologies are indicated from left to right together with the corresponding three-dimensional structures. The
proteins are oriented by first superposing them according to DALI (Holm and Sander, 1996) and then translation. The regions belonging to
the OB fold consensus are colored in cyan both in the structures and in the cartoon representations.sandwiched between strands β3–β9 and β1–β2, whereas
strands β1 and β2 form an independent antiparallel
β sheet in close contact with α1 and are located on the
concave side of the cavity. In addition, the first five
N-terminal amino acids of ATX1 AXH flank β5 and spa-
tially substitute β1 of HBP1_AXH, whereas α2 replaces
the C terminus of HBP1_AXH. The other appreciably
different region is the last ten amino acids (336–345),
which, in HBP1_AXH, bends back to form a stable in-
teraction between F345 and W309; however, in ATX1
AXH, it follows β3.
These results indicate that the AXH domain has a
chameleon structure in which the N and C termini can
adopt distinctly different conformation.
Comparison of AXH with Other OB Folds
A search for tertiary structure similarity performed by
DALI (Holm and Sander, 1996) indicates that the AXH
of ATX1 (monomer A) is the most similar one to HBP1_
AXH (Z score of 7, rmsd of 3.8 Å over 84 amino acids).
Other protein structures with an OB fold follow in the list
with Z scores in the range of 3.2–2.0. They include the
DNA binding domain A of the Replication Protein A (RPA,
1fgu), the photoactive yellow protein (3pyp), and the RNA
binding domain of ribosomal protein L2 (N-terminal do-
main) (1rl2).
In the most common case of a closed barrel, the OB
fold consists of two three-stranded antiparallel β sheets,
in which β1 is shared by both sheets, while β3 and β5
close the barrel by forming a parallel network of hy-
drogen bonds (Murzin, 1993) (Figure 3). However, thereare several examples in which the barrel is only partially
closed, as in both HBP1 and ATX1 AXH domains (Theo-
bald et al., 2003). HBP1_AXH represents a topological
variation of this fold, as in the recently published struc-
ture of the Ago2 PAZ domain (Lingel et al., 2003). The
presence of strands β1 and β2 in addition to β3, β4, β5,
and β9 makes the central barrel of HBP1_AXH more
similar overall than ATX1 AXH to the canonical OB fold.
Sequence Alignment of the AXH Family Revisited:
Implications for Binding Site Predictions
Previous AXH sequence alignments produced only on
the basis of sequence similarity (de Chiara et al., 2003;
Chen et al., 2004) can be revised by using the structural
information now available for both protein families (Fig-
ure 4A). If the alignment is based on the secondary
structure of the two proteins, a gap must be inserted in
different positions of each of the ATX1 and of the HBP1
families to obtain a reasonable alignment of β2 (resi-
dues 231–233). The stretch between residues 244 and
253 of the HBP1_AXH sequence, previously aligned
with the region preceding strand β3 in ATX1 AXH (resi-
dues 606–615) (de Chiara et al., 2003), contains the un-
structured loop that, therefore, results in a long inser-
tion. However, if the alignment is based on the tertiary
structures of the two proteins, only regions 260–335 of
HBP1_AXH and 612–684 of ATX1 AXH can be meaning-
fully aligned.
Using this revised alignment, we may identify resi-
dues that are essential for the fold stability and can
distinguish these from those potentially important for
Structure
748functional reasons. Most of the 27 residues completely s
iconserved throughout the family are buried and there-
fore important for keeping the structural integrity of the (
gdomain. Only seven exposed positions are conserved
(K217, E235, D236, E268, G285, P324, and N344), in s
Kagreement with the apparent evolutionary distance be-
tween the two protein families. In addition, the exposed s
cpositions corresponding to K225, E230, W231, R239,
A240, E246, E269, L298, K307, E327, L328, I330, and w
cN341 in HBP1_AXH are semiconserved. Together, the
conserved and semiconserved residues cluster into b
two exposed patches, suggesting at least one common
partner (Figure 4B). R
oExposed nonconserved hydrophobic surfaces may be
involved instead in interactions with distinct partners. W
oResidues L265, V287, and L291 of HBP1_AXH (which are
hydrophilic positions in ATX1_AXH) form, for instance, an e
Texposed hydrophobic patch closely clustered on the sur-
face (data not shown). Similarly, the nearby residues o
AL298, L316, L318, and V319 form a hydrophobic ridge
that could be involved in recognition of a complemen- b
btary groove. Finally, the retinoblastoma protein second-
ary binding site predicted at residues 323–327 of HBP1 m
sis only semiaccessible, with two of the hydrophobicFigure 4. Sequence Comparison of the AXH Family
(A) Sequence alignment of the AXH family based on secondary structure information. The alignment was produced by ClustalX (Thompson
et al., 1997). The secondary structure elements as observed in the respective HBP1_AXH and ATX1_AXH (subunit A) structures are reported
in the HBP1_SS and ATX1_SS lines. The sequence numbering refers to HBP1 (top) and ATX1 (bottom), respectively.
(B) Space-filling representation of the HBP1_AXH indicating positions conserved (dark green) and semiconserved (light green). The structure
is displayed by using the same view adopted in Figure 1 (left) and a view rotated by 180° around the y axis (right).ide chains (I323 and C325) packing onto the protein
nterior. From a mutational analysis of position 3
C325G) of this domain, it was suggested that it, to-
ether with the principal retinoblastoma protein binding
ite, is essential for recognition (Tevosian et al., 1997).
nowledge of the HBP1_AXH structure suggests in-
tead that this rather drastic mutation, which affects a
onserved buried cysteine involved in a hydrogen bond
ith a spatially close equally conserved serine (S311),
ould destabilize the domain fold, rather than affect a
inding surface directly.
NA Binding Is a Conserved Property
f the AXH Domain
e have demonstrated recently that the AXH domain
f ATX1 is able to bind RNA homopolymers, with prefer-
nce for poly(rG) and poly(rU) (de Chiara et al., 2003).
his preference corresponds to the same specificity
bserved for the full-length protein (Yue et al., 2001).
n important question is whether or not nucleic acid
inding is a function also conserved in HBP1. RNA
inding of HBP1_AXH was tested by using the four ho-
opolymers immobilized on agarose beads as de-
cribed previously both for full-length ATX1 and for
Solution Structure of the HBP1 AXH Module
749Figure 5. RNA Binding Assays
(A) p(rC), p(rA), p(rU), and p(rG) homopolymers were immobilized
on agarose beads (lanes 1–4, respectively). The markers and their
molecular weights are indicated in the last lane.
(B) Comparison between the structures of a representative OB/
nucleic acid complex (the DNA complex of DNA binding domain A
of RPA, 1fgu) with HBP1_AXH. In the RPA complex (left), the DNA
and the side chains of residues involved in binding are indicated
explicitly in purple and blue, respectively. In HBP1_AXH (right), the
side chains of completely and semiconserved residues are indi-
cated in yellow and green, whereas additional lysines and arginines
that could contribute to the binding are shown in red. The view is
the same as in Figure 4.ATX1_AXH (de Chiara et al., 2003; Yue et al., 2001). The
construct was able to bind the RNA homopolymers
even at high ionic strength (Figure 5A). Poly(rU) and
poly(rA) were recognized with approximately the same
affinities, whereas weaker or no binding was observed
for poly(rG) and poly(rC). These findings suggest that
nucleic acid binding is a property of the AXH domain
conserved both in HBP1 and in ATX1. The residues
involved in nucleotide binding could therefore be
amongst the conserved or semiconserved ones. Al-
though the large variability that OB fold domains dis-
play in their mode of nucleic acid binding makes any
prediction hard, it is interesting to notice that one of the
two conserved patches is located around the region in
which many of the known OB fold proteins accommo-
date their nucleic acid target (i.e., near the loops be-
tween the strands β1 and β2, β2 and β3, and β4 and β5,
and the loop between β3 and α) (Theobald et al., 2003)
(Figure 5B). Additional nonconserved sites may contrib-
ute to determining the different sequence specificities
of the two proteins.AXH from ATX1, but Not from HBP1, Has a Strong
Tendency to Aggregate and Form Fibers
During the characterization of the constructs used in
this and in previous studies (de Chiara et al., 2003), we
had noticed that the HBP1_AXH domain is stable and
remains monomeric for several months (up to 1–2
years) when kept at 4°C after purification, whereas an
ATX1 AXH construct spanning residues 568–694 (here-
after indicated as ATX1_AXH), which is approximately
equivalent to that used for crystallography (563–694),
showed a strong tendency to aggregate. We explored
systematically this property by analytical gel filtration
and electron microscopy. When a freshly prepared
sample of ATX1_AXH was loaded on a gel filtration col-
umn (Superdex-75), the elution profile showed two
main peaks at an approximately 1:1 ratio. One peak (ca.
44%) corresponds to the molecular weight of the dimer,
in agreement with ultracentrifugation data (de Chiara et
al., 2003; Chen et al., 2004), the other (ca. 56%) corres-
ponds to a high-molecular weight aggregate that ex-
ceeds the capacity of the column (100 kDa) (Figure 6A).
A third minor species corresponding to a w60 kDa mo-
lecular weight species, i.e., close to the value expected
for a tetramer, is also detectable as a shoulder of the
aggregate. This species could represent an intermedi-
ate of the aggregate formation and could correspond
to the crystallographic dimer of dimers. If the two spe-
cies were separated and the fraction corresponding to
the dimer was reloaded on the gel filtration column with
an approximately 45# lag time, the aggregate species
reappears. The relative amount of the aggregate in-
creases progressively up to complete disappearance of
both the dimeric and the tetrameric forms, indicating
irreversibility of the aggregation process.
The temperature plays a critical role in the rate of the
process: when the sample was incubated at 4°C, an
almost complete aggregation (>95%) was reached after
6 days, whereas the process took 4 days and less than
24 hr when the sample was incubated at 22°C at 37°C,
respectively. Under similar conditions, however, the ki-
netics are slower at lower pH (within the pH interval
6.5–8.0) and at lower protein concentrations (data not
shown).
The same samples loaded on gel filtration were
checked by electron microscopy (EM), and all revealed
the presence of flexible, unbranched fibrillar aggre-
gates between 30 and 50 nm long and <5 nm wide with
a ribbon-like morphology (Figure 6B). Electron micro-
graphs obtained from ATX1_AXH samples incubated at
higher temperature contain relatively longer and more
regular fibrils. For comparison, samples of HBP1_AXH
treated in the same conditions did not show any aggre-
gate or fibril formation.
Discussion
AXH is a sequence motif that seems to play an impor-
tant functional role in both protein families in which it
has been so far identified (de Chiara et al., 2003). We
have described here the solution structure of the AXH
domain from HBP1, a negative regulator of several cell
cycle- and differentiation-specific genes. The new struc-
ture reveals that the HBP1 AXH domain adopts a per-
Structure
750Figure 6. Tendency of ATX1_AXH to Aggregate
(A) Elution profiles of analytical gel filtration experiments performed on a freshly purified ATX1_AXH sample (100 M protein concentration in
20 mM Tris-HCl (pH 8.0), 20 mM NaCl, 2 mM β-mercaptoethanol). The protein was incubated at 22°C and was injected in the column
immediately after concentration (continuous line) after 24 hr (dashed line), 3 days (dotted line), and 4 days (dotted and dashed line).
(B) EM micrograph of a sample of ATX1_AXH treated as in (A) but incubated at 37°C for 24 hr.
(C) For comparison, EM micrograph of an HBP1_AXH treated as in (B). The bar corresponds to 50 nm.mutation of the OB fold, one of the most widely spread β
bmotifs for single-stranded DNA or RNA recognition (Theo-
bald et al., 2003). We show experimentally that, like the e
fAXH of ATX1, HBP1_AXH is able to recognize RNA ho-
mopolymers with base specificity. This result suggests
ga previously unidentified function of HBP1, so far known
only as a sequence-specific double-stranded DNA bind- o
sing protein through its N-terminal HMG domain (Zhuma
et al., 1999). HBP1 would not be the first example of a l
itranscription factor that binds both DNA and RNA,
since an increasing number of sequence-specific DNA u
nbinding transcription factors, including the prototypic
Xenopus TFIIIA protein and the mammalian p53, bind i
lRNA with some specificity (Cassiday and Maher, 2002).
Like p53, HBP1 could have two distinct domains spe- a
scialized for DNA and RNA binding. Conservation of nu-
cleic acid binding in both protein families sharing an p
sAXH domain also suggests the presence of a novel
binding motif conserved in both proteins. When at- c
tempting to rationalize the suggested common role of
polyQ proteins in RNA metabolism, identification and u
scharacterization of this site will be particularly impor-
tant for ATX1 (Nollen et al., 2004; Fernandez-Funez et a
Aal., 2000).
An even more interesting result arising from our study A
eis that, although sharing a similar OB fold, the struc-
tures of the AXH domains from ATX1 and HBP1 have m
agenuinely distinct folds. The differences are not, as in
other chameleon sequences, determined by a different l
ptendency to adopt distinct secondary structures: the
two folds share the same secondary structure ele- o
aments, but these are differently arranged in space. Nei-
ther of the differences are induced by binding to an- 2
Nother molecule. AXH is probably the first example in
which homologous protein modules present such a a
wstrikingly different three-dimensional arrangement. It is
worth noticing that such a result could not be easily s
ganticipated by sequence comparison since, despite the
presence of the large flexible insertion between α and A13 in HBP1_AXH, the two sequences share an apprecia-
le degree of homology throughout their lengths. This
xample will therefore be an important reference for
old predictions based on comparative modeling.
The isolated ATX1_AXH, but not HBP1_AXH, aggre-
ates spontaneously and also forms fibers under physi-
logic conditions, that is without being exposed to de-
tabilizing agents such as high temperature or pressure,
ow pH, or solvent perturbation. Since the HBP1_AXH
s monomeric and stable both against aggregation and
nfolding, we may suggest that this fold represents the
ative structure of AXH. The alternative fold observed
n the crystal structure of the ATX1_AXH dimer, overall
ess compact than that of HBP1_AXH, could represent
n intermediate species, trapped in the crystal, which
eeds aggregation. If this hypothesis were true, we ex-
ect that other conformations of the AXH domain
hould be detectable by changing the experimental
onditions.
An increasing number of proteins, also apparently
ncorrelated with pathologies, has recently been
hown to be able to aggregate and form fibers (Uversky
nd Fink, 2004). However, the observation of alternative
XH folds together with the aggregation propensity of
TX1_AXH are particularly intriguing in light of the pres-
nce of this domain in ATX1, a protein involved in a
isfolding disease. The aggregation properties of ATX1
nd of other polyQ proteins have been thought for a
ong time to be determined solely by expansion of the
olyQ tract. More recently, increasing evidence points
ut the importance of the protein context in modulating
nd fine tuning the aggregation process (Nozaki et al.,
001; Masino et al., 2002; La Spada and Taylor, 2003).
ot only it is now well established that fusion with suit-
ble protein carriers is sufficient to solubilize the other-
ise insoluble polyQ, but both in vitro and in vivo
tudies strongly suggest that polyQ is not the only re-
ion able to aggregate and/or cause cell toxicity.
taxin-3, another member of the polyQ family, is able
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751to aggregate and form fibers also in its nonexpanded
form (Chow et al., 2004; Marchal et al., 2003; Masino et
al., 2003; Shehi et al., 2003). This behavior was recently
mapped onto the N-terminal Josephin domain of
ataxin-3, which, when isolated, has features indistin-
guishable from those observed for the nonexpanded
full-length protein (Masino et al., 2004). In vivo gain of
toxicity, normally associated with polyQ expansion of
ATX1, also results from an excess of the nonexpanded
protein (Fernandez-Funez et al., 2000).
PolyQ expansion could therefore have a strong and
determinant role in destabilizing the native fold of these
other regions and in leading the entire protein to its mis-
folded state. The possibility that polyQ regions can in-
fluence the folding pathway is supported by the obser-
vation that insertion of a short glutamine repeat into
chymotrypsin inhibitor 2 leads to domain swapping and
dimerization (Chen et al., 1999). The work of Bevivino
and Loll (2001) was also interpreted by concluding that,
in addition to promoting aggregation, polyQ expansion
may alter and destabilize the native state of ataxin-3.
We propose that the highly fibrillogenic ATX1_AXH
chameleon is one of these regions and is implicated in
the misfolding of ATX1. A link between AXH and polyQ
is already known since the binding efficiency of several
partners whose interaction sites have been mapped
onto the AXH domain is correlated with the length of
polyQ (de Chiara et al., 2003; Yue et al., 2001; Hong et
al., 2002; Matilla et al., 1997), thus indicating that the
tertiary arrangement of ATX1 brings the AXH spatially
close to the polyQ tract. A more detailed description of
the structural properties of ATX1 and of other polyQ
proteins will be necessary to test this hypothesis and
to fully understand the precise role of these proteins in
neurodegeneration.
Experimental Procedures
Protein Sample Preparation
The HBP1_AXH and ATX1_AXH constructs were produced as His-
tagged GST fusion proteins, cleaved from the tag by using a to-
bacco etch virus (TEV) protease cleavage site, and purified to
homogeneity as described in detail elsewhere (de Chiara et al.,
2003, 2004). After purification, the buffer was exchanged by dialy-
sis to 20 mM Tris-HCl (pH 7.0) with 10 mM NaCl, 2 mM β-mercapto-
ethanol, and 0.02% NaN3 and was concentrated. NMR samples
had a typical concentration of 0.3–0.7 mM. A complete EDTA-free
protease inhibitor (Roche) cocktail was added to prevent proteo-
lytic degradation to the final sample from a stock solution (1 tablet/
2 ml) by using a 1/50-fold dilution.
Experimental Restraints
Resonance assignment of HBP1_AXH was performed as described
(de Chiara et al., 2004). During the structure determination process,
the assignment of the small number of aromatic side chain reso-
nances missing at the stage of the assignment deposition was
completed (de Chiara et al., 2004). Interproton distance restraints
were derived from NOESY-15N- and NOESY-13C-HSQC spectra ac-
quired at 30°C with a mixing time of 100 ms on a Varian Inova
spectrometer operating at 800 MHz 1H frequency. 74 f and ϕ dihe-
dral angles were obtained by using the backbone torsion angle
prediction package TALOS (version 98.04.21.02) (Cornilescu et al.,
1999), whereas 82 f dihedral angles resulted from 3JNH-Hα esti-
mated from a three-dimensional HNHA spectrum and 34 χ1 torsion
angle restraints were determined from the relative intensities of in-
traresidue HN-Hβ NOEs in conjunction with the 3JHNHβ coupling
from three-dimensional HNHB (Archer et al., 1991). Amide protec-tion was inferred from deuterium exchange measurements per-
formed at 30°C on a freeze-dried, 15N-labeled sample, redissolved
in a Tris-HCl buffered (pH 7.0) D2O solution. A total of 31 slowly
exchanging protons were identified as observable signals in a 60
min 1H-15N HSQC spectrum initiated immediately after redissolving
the freeze-dried protein. A hydrogen bond restraint involving a
slowly exchanging proton was added if a hydrogen bond was con-
sistently observed in at least 50% of the initial structures in-
spected. 1DNH residual dipolar couplings (RDC) were measured at
30°C, aligning the protein in 5% n-dodecyl-penta(ethylene glycol)/
n-hexanol (r = 0.92) by using a buffer made of 20 mM Tris-HCl, 20
mM NaCl, 2 mM β-mercaptoethanol, 0.02% NaN3 (pH 7.0). The li-
quid crystalline media gave a stable quadrupolar splitting of the
D2O signal of 21 Hz. The final concentration of the protein in this
media was w0.37 mM. Precise measurements of 1JNH splittings
were obtained from IPAP-[15N,1H]-HSQC spectrum (Ottinger et al.,
1998). RDC were applied for an alignment tensor with an axial com-
ponent of −6 Hz and a rhombicity of 0.5 (Warren and Moore, 2001).
T1, T2, and heteronuclear NOE measurements were performed
at 30°C by using pulse sequences adapted from standard pulse
sequences. The T1/T2 ratios for residues not undergoing large-
amplitude motions or exchange were used to estimate a correlation
time (τc) value according to the model-free approach (Lipari and
Szabo, 1982). Residues with T1 and T2 values that differ more than
one standard deviation from the mean were excluded from the τc
calculation.
Structure Calculation of HBP1_AXH
Structure calculations were performed by using the ARIA program
(version 1.2) (Linge et al., 2001). A typical run consisted of nine
iterations. Iteration 0 generates the initial ensemble of structures
with NOE violation tolerance set to 1000 Å and the partial assign-
ment cutoff probability set to 1.01 so that no NOE distance re-
straints are excluded, while the partial NOE assignments are based
on chemical shifts only. In the following eight iterations, the NOE
violation tolerances are progressively reduced (1000.0, 1.0, 0.5, 0.1,
1.0, 0.1, 0.1, and 0.1 Å), as the structures improve, with the excep-
tion of iteration 5, in which the violation tolerance is increased to 1 Å
to ensure that important NOEs consistent with the structure at that
stage are not excluded. The partial assignment cutoff probability is
reduced in parallel (0.9999, 0.999, 0.99, 0.98, 0.96, 0.93, 0.90, and
0.80) in order to eliminate ambiguous NOEs that do not contribute
significantly to the current structure. In each ARIA iteration, 20
structures were calculated by simulated annealing by using the
standard CNS protocol (Brunger et al., 1998). Floating assignment
for prochiral groups and correction for spin diffusion during itera-
tive NOE assignment were applied as described (Folmer et al.,
1997; Linge et al., 2004). At the end of each iteration, the best seven
structures in terms of lowest global energy are selected and used
for the assignment of additional NOEs during the following itera-
tion. In the final ARIA run, the number of structures generated in
iteration 8 was increased to 100, and after refinement by molecular
dynamics simulation in water (Linge et al., 2003), the 20 lowest energy
structures were selected as representative of the HBP1_AXH struc-
ture and were used for statistical analysis.
As an initial test to determine the protein fold, preliminary struc-
tures were generated on the bases of 1850 total unambiguous
NOEs manually assigned, derived from 15N and 13C spectra, and of
TALOS dihedral backbone restraints. Once the structures consis-
tently started to converge to a unique fold, the number of manually
assigned NOEs was gradually decreased. The ARIA input used to
generate the final structures consisted of unassigned NOE cross-
peaks from NOESY-15N-HSQC and NOESY-13C-HSQC spectra,
manually picked to exclude noise and artifacts deriving from spin
diffusion effects, along with f, ϕ, and χ1 dihedral angles, hydrogen
bonds, and a complete chemical shift assignment (de Chiara et al.,
2004). Starting from this data set, the ARIA run converged rapidly
without the use of any manually assigned NOE distance restraints.
In the final iteration, 3048 unambiguous and 567 ambiguous NOEs
were assigned. Among the 3615 total NOEs, 1256 were intra-
residue, 740 were sequential, 322 were medium range, and 1297
were long range. The structures so obtained were further refined by
using 58 1DNH RDCs. The rmsd in Hz from residual dipolar coupling
restraints (observed − calculated) is 0.460 ± 0.028.
Structure
752Structure quality was evaluated by using the programs PRO- B
ACHECK (Laskowski et al., 1996) and WHATIF (Vriend, 1990). The
resulting quality is in excellent comparison with the values reported (
1for the pleckstrin homology domain when using the same ARIA
protocol (Linge et al., 2004). B
d
RNA Binding Assay p
RNA binding to homopolymers was probed by following the assay B
described by Yue et al. (2001). 0.5 ml of 3 µg solutions of the puri- G
fied uncleaved His-tagged, GST-fused proteins in the binding buffer P
(10 mM Tris-HCl [pH 7.4], 2 mM MgCl2, 0.5% Triton, 150 mM NaCl) were s
individually mixed with agarose bound poly(rA), poly(rU), poly(rG), and C
poly(rC) beads (Sigma or Amersham) (50 µl fully swollen matrix in
Cthe binding buffer). The mixture was left to incubate for 4 hr at 4°C.
tThe beads were pelleted with a short spin in a microfuge and were
3washed four times with 600 µl binding buffer prior to resuspension
Cin SDS-PAGE loading buffer. Bound proteins were eluted from nu-
acleic acid by boiling, were redissolved in an SDS-polyacrylamide
ggel, were transferred to PDVF membrane (Amersham), and were
visualized by immunoblot. Filters were processed and probed by C
using a monoclonal anti-6-His-tag antibody. The assay was re- M
peated twice to check reproducibility. t
a
Gel Filtration Experiments l
A prepacked Superdex-75 HR 10/30 column (Pharmacia) was equi- C
librated with Tris-HCl buffer (pH 7.0), 200 mM NaCl, 2 mM β-mer- (
captoethanol, 0.02% NaN3. Albumin (67 kDa), ovalbumin (43 kDa), a
carbonic anhydrase (29 kDa), chymotrypsinogen A (25 kDa), and
Cribonuclease A (13.7 kDa) were used as standards for the molecular
tweight calibration. Blue Dextran 2000 was used for the determina-
etion of the void volume of the column. A freshly prepared ATX1_AXH
psample (100 M) in 20 mM Tris-HCl (pH 8.0), 20 mM NaCl, 2 mM
Cβ-mercaptoethanol was incubated at 4°C, 22°C, and 37°C. Aliquots
a(100 l) were loaded into the column at variable times by using a
sstatic loop (2 ml) and were eluted with the same equilibrating buffer
at 0.5 ml/min. HBP1_AXH was treated in a similar way. d
R
EM Measurements m
EM measurements were performed both on ATX1_AXH and HBP1_ H
AXH samples incubated for a variable time at different temper- d
atures as previously described for the gel filtration experiments. s
Additional testing was done by using samples (typically at 0.4–0.6 t
mM concentrations) that had been used for NMR measurements
Dfor 1–2 weeks and later incubated at 4°C for ca. 6 months. Samples
awere applied to carbon-coated grids and stained with 1% sodium
isilico-tungstate (pH 7). The grids were viewed under minimum dose
Mand accurate defocus conditions with a Jeol 1200EX operated at
D100 kV.
T
D
Supplemental Data l
Supplemental Data including details about the structure validation 3
and an analysis of the crystal structure of the AXH from ATX1 are F
available at http://www.structure.org/cgi/content/full/13/5/743/DC1/. W
M
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